Balbino Alarcón
- Immunology top 0.2%
- T-cell and B-cell Immunology 89
- Immune Cell Function and Interaction 83
- Immunotherapy and Immune Responses 22
- Oncology top 1%
- CAR-T cell therapy research 28
- Immunology and Allergy top 2%
-
- Monoclonal and Polyclonal Antibodies Research 28
- Physiology top 2%
-
- Glycosylation and Glycoproteins Research 15
-
- Chronic Lymphocytic Leukemia Research 7
-
- SARS-CoV-2 and COVID-19 Research 6
- Co-authors
- Wolfgang W. SchamelCox TerhorstAndrés AlcoverThomas WilemanHans CleversFrancisco Sánchez‐MadridDiana GilPilar Delgado
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Balbino Alarcón
152 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Immunology 4.9k
- Oncology 1.9k
- Immunology and Allergy 330
- Radiology, Nuclear Medicine and Imaging 1.1k
- Physiology 154
Countries citing papers authored by Balbino Alarcón
This map shows the geographic impact of Balbino Alarcón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Balbino Alarcón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Balbino Alarcón more than expected).
Fields of papers citing papers by Balbino Alarcón
This network shows the impact of papers produced by Balbino Alarcón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Balbino Alarcón. The network helps show where Balbino Alarcón may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Balbino Alarcón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 51 | |
| 11 | 2020 | 19 | |
| 12 | 2018 | 26 | |
| 13 | 2018 | 9 | |
| 14 | 2011 | 136 | |
| 15 | 2007 | 66 | |
| 16 | 2002 | 38 | |
| 17 | 2002 | 367 | |
| 18 | 2000 | 101 | |
| 19 | 1997 | 16 | |
| 20 | 1991 | 60 |
About Balbino Alarcón
Balbino Alarcón is a scholar working on Immunology, Oncology and Physiology, having authored 156 papers that have together received 7.2k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (89 papers), Immune Cell Function and Interaction (83 papers), Monoclonal and Polyclonal Antibodies Research (28 papers), CAR-T cell therapy research (28 papers), Immunotherapy and Immune Responses (22 papers), Glycosylation and Glycoproteins Research (15 papers), Chronic Lymphocytic Leukemia Research (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). The work is most often cited by research in Immunology (4.9k citations), Oncology (1.9k citations) and Immunology and Allergy (330 citations). Balbino Alarcón has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Wolfgang W. Schamel, Cox Terhorst, Andrés Alcover, Thomas Wileman, Hans Clevers, Francisco Sánchez‐Madrid, Diana Gil, Pilar Delgado, Susana Minguet and Mahima Swamy. Their work appears in journals such as Nature, New England Journal of Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.